Total assets decreased 81.1%
Total assets changed -81.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$1.8B→$338.3M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →NPWR financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Stockholders' equity decreased 86.4%
Stockholders' equity changed -86.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$616.2M→$83.5M4 prior comparisons
Working capital / assets moved 6680 bp higher
Working capital / assets changed +6680 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
20.49%→87.29%4 prior comparisons
Current ratio increased 82.3%
Current ratio changed +82.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
9.77→17.84 prior comparisons
Free-cash-flow proxy increased 62.3%
Free-cash-flow proxy changed +62.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-$27.7M→-$10.4M2 prior comparisons
Operating cash flow increased 60.8%
Operating cash flow changed +60.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-$24.6M→-$9.6M2 prior comparisons
Operating income decreased 131.8%
Operating income changed -131.8% from the comparable as-filed period.
-$90.6M→-$209.9M1 prior comparisons
Current liabilities decreased 58.0%
Current liabilities changed -58.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$41.8M→$17.6M4 prior comparisons
Net income decreased 185.3%
Net income changed -185.3% from the comparable as-filed period.
-$28.1M→-$80.3M1 prior comparisons
Cash & equivalents decreased 58.5%
Cash & equivalents changed -58.5% from the comparable as-filed period.
$284.0M→$117.9M3 prior comparisons
Research & development decreased 84.1%
Research & development changed -84.1% from the comparable as-filed period.
$26.6M→$4.2M1 prior comparisons
Capital expenditure decreased 74.4%
Capital expenditure changed -74.4% from the comparable as-filed period.
$3.1M→$793,0002 prior comparisons
Stock-based compensation decreased 85.8%
Stock-based compensation changed -85.8% from the comparable as-filed period.
$13.9M→$2.0M1 prior comparisons
Current assets decreased 23.4%
Current assets changed -23.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$408.5M→$312.9M4 prior comparisons
Working capital decreased 19.5%
Working capital changed -19.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$366.7M→$295.3M4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.